-
Chaperone Technologies Earns New Patent in Its Fight Against Drug-Resistant Bacteria
Ben Franklin client Chaperone Technologies, a biotechnology company developing an entirely new class of antimicrobials, has received the formal issuance from the United States Patent and Trademark Office for one of its patent applications. This represents a major step in the global fight against drug-resistant bacteria. The patent claims are directed in part to Chaperone’s Continue Reading…